Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 32 Breast Neoplasms 21 Neoplasms 17 Prostatic Neoplasms 11 Obesity 8 Colorectal Neoplasms 6 Sarcopenia 5 Pancreatic Neoplasms 5 Lung Neoplasms 5 Polycystic Ovary Syndrome 4 Head and Neck Neoplasms 4 Signs and Symptoms 3 Multiple Myeloma 3 Lymphedema 3 Inflammation 3 Fatigue 3 Diabetes Mellitus, Type 2 3 Colonic Neoplasms 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Pharyngeal Neoplasms 2 Overweight 2 Osteoporosis, Postmenopausal 2 Osteoporosis 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Laryngeal Neoplasms 2 Insulin Resistance 2 Endometrial Neoplasms 2

Interventions

Temozolomide 109 Magnetic Resonance Spectroscopy 52 Bevacizumab 52 Radiotherapy 44 Irinotecan 27 Blood Specimen Collection 19 Surgical Procedures, Operative 16 Radiation 15 Aminolevulinic Acid 15 Carboplatin 13 fluorodopa F 18 12 Nivolumab 12 Radiotherapy, Intensity-Modulated 11 Carmustine 11 Radiosurgery 10 Magnetic Resonance Imaging 10 pembrolizumab 9 Topotecan 9 Specimen Handling 9 Everolimus 9 Erlotinib Hydrochloride 9 Biopsy 9 poly ICLC 8 Surveys and Questionnaires 8 Standard of Care 8 Etoposide 8 Drug Therapy 8 Lomustine 7 Filgrastim 7 Cyclophosphamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioma × Resistance Training × Clear all

NCT03775369 2022-05-18

Glioma and Exercising

University Hospital, Basel, Switzerland

Phase NA Completed

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡